Impaired ABCA1 function (due to polymorphisms or downregulation in disease states) leads to reduced ApoE lipidation, diminished Aβ clearance, and increased Aβ and tau pathology, and accelerates cognitive decline [15,20,21]. The gene discussed is MAPT; the disease is Mental deterioration.